Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersSurgical Oncology Physician in New York, NY
NPI: 1013179878Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get M.D. George's Phone Numberphone_androidMobile
Get M.D. George's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2008 - 2027
American Board of Surgery
Surgery
New York University School of Medicine
Medical School
Until 2002
Memorial Sloan Kettering Cancer Center
Fellowship • Complex General Surgical Oncology
—
NYU Grossman School of Medicine
med.nyu.edu
Residency • Surgery
2002 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 130 | 161 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 32 | 32 |
| 3 | 19301Partial removal of breast | 24 | 27 |
| 4 | 38525Biopsy or removal of lymph nodes of under the arm, open procedure | 15 | 15 |
| 5 | 38900Lymph node imaging during surgery | 13 | 13 |
Tumor resident regulatory T cells
Authors: Glasner, Ariella, Plitas, George
Journal: Semin Immunol
Publication Date: 2021-04-24
The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Authors: Sandra Dangelo, Evan Rosenbaum
Publication Date: 2021-05-23
The association between tumor mutational burden and prognosis is dependent on treatment context
Authors: Nadeem Riaz, Richard Wong, Michael Postow, Abraham Hakimi, Aimee Crago, Luc Morris, Alexander Shoushtari, Jesse Smith, Ian Ganly, Kara Long Roche, Vinod Balachandran
Journal: Nat Genet
Publication Date: 2021-01-04
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Sargramostim, PROCEDURE: Surgical Procedure, DRUG: Nelipepimut-S Plus GM-CSF Vaccine
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Cedars-Sinai Medical Center
Intervention / Treatment: DRUG: cisplatin, RADIATION: external beam radiation therapy, PROCEDURE: Biopsy of Target Tumor